WHO Recommends GLP-1 Drugs for Obesity in Major Global Health Update
Published on: Dec. 3, 2025, 7:38 a.m. | Source: Times Now
The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of weight-related complications. Citing strong evidence for significant weight loss and improved health outcomes, the agency says these medications should be used alongside lifestyle changes. The guidance marks a major shift in global obesity care. , Health, Times Now
